HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantification of metamorphopsia in patients with epiretinal membranes.

AbstractPURPOSE:
To quantify the degree of metamorphopsia in patients with idiopathic epiretinal membranes (ERMs), by use of a new metamorphopsia chart (M-CHARTS) developed by the authors.
METHODS:
These M-CHARTS had 19 dotted lines with dot intervals of between 0.2 degrees (fine) and 2.0 degrees (coarse) visual angles. As the dot intervals were changed from fine to coarse, a decrease in the severity of metamorphopsia was noted. In this study, the minimum visual angle of the dotted lines needed to cause the metamorphopsia to disappear was measured in 51 eyes of 51 patients with ERM. The metamorphopsia scores were compared with the stages of ERM classified by scanning laser ophthalmoscope (SLO) images.
RESULTS:
In patients with ERM, the metamorphopsia score increased depending on the severity of membrane proliferation classified by SLO images. The scores obtained from the horizontal dotted lines were larger than those of the vertical lines in advanced stages of ERM.
CONCLUSIONS:
M-CHARTS provide a very simple and useful method for evaluating the severity of metamorphopsia in patients with ERM.
AuthorsChota Matsumoto, Eiko Arimura, Sachiko Okuyama, Sonoko Takada, Shigeki Hashimoto, Yoshikazu Shimomura
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 44 Issue 9 Pg. 4012-6 (Sep 2003) ISSN: 0146-0404 [Print] United States
PMID12939323 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Epiretinal Membrane (diagnosis)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Ophthalmoscopy
  • Vision Disorders (diagnosis)
  • Vision Tests (instrumentation)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: